BCMA-directed T cell engager
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCMA-directed T cell engager, covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager [Phase 4]